Announcements

The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.
(February 6, 2026) The Reagan-Udall Foundation for the FDA (Foundation) has appointed Adrian F. Hernandez, MD, MHS, as Chair of its Board of Directors. Dr. Hernandez, who has served on the Board since 2019, is a cardiologist and the Vice Dean for…
The Reagan-Udall Foundation for the FDA will honor the Produce Safety Alliance, Critical Path Institute, and Loren A. Eng with its Innovations in Regulatory Science & Policy Awards on December 9, 2025.

Coverage

Oncology clinical trials represent a dynamic frontier where site selection optimization directly influences the pace of innovation and the relevance of therapeutic advances.
In September 2024, a stakeholder roundtable report published by the Reagan-Udall Foundation for the FDA indicated that industry stakeholders may not be aware of or prepared to be in compliance with the rule by January 2026.
Moderator Michael McCaughan and Dr. Amy Abernethy kicked off the fireside chat by reflecting on the evolution of RWD, including prior efforts such as the Friends RWD Pilot 1.0 Project and the COVID-19 Evidence Accelerator led by Friends and the Reagan-…